Ensuring Safety

Ensuring the safety of your trial participants is the most important task when conducting a clinical trial.

Sponsor-Investigators, site Principal Investigators (PIs) and their research staff, institutions and ethics committees all have a responsibility to monitor, assess and report safety events that occur in investigator-initiated trials (IITs).  

Institutions should have standard operating procedures and supporting guidelines and templates to help everyone monitor and report safety events for IITs.  

See the MCRI: SOP Monitoring Visit Activities for Clinical Trials of Investigational Products for an example.

Responsibilities and decision-making

The process for reporting safety events can be confusing. To make it easier to understand here are two process maps that show the responsibilities and decision-making process for both the Sponsor-Investigator and site PIs when monitoring, assessing, reporting and documenting safety events:

Regulatory guidelines


Get the latest in cancer news, events and more, direct to your inbox
Join a network of Victorian cancer researchers, clinicians and consumers to keep your finger on the pulse.